In the miR-383/EIF5A2 pathway, miR-383 overexpression and EIF5A2 silencing sensitized HCC cells to doxorubicin-induced cytotoxicity and apoptosis, whilst miR-383 inhibition exerted opposite effects. The gene discussed is EIF5A2; the disease is hepatocellular carcinoma.